PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.\', \'Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'Laboratory of Immune-Regulation, Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.\', \'CIBERES, CIBER Enfermedades Respiratorias, Madrid, Spain.\', \'Departamento De Medicina. Facultad De Medicina, Universidad Complutense De Madrid, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/17512433.2021.1875819
?:hasPublicationType
?:journal
  • Expert review of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33499687
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.833
?:rankingScore_hIndex
  • 29
?:title
  • Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33499687>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33499687>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all